Introduction: FOXO4-DRI peptide allows selective apoptosis of senescent cells, supports metabolic studies, and assures security in study, improving reproducibility and advancing ageing and oncology investigations. everyday laboratory workflows usually reveal gaps in which existing compounds are unsuccessful to deal with mobile senescence comprehen